The Bronchodilators Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).


Learn More On The Bronchodilators Market:
https://www.thebusinessresearchcompany.com/report/bronchodilators-global-market-report

According to The Business Research Company’s Bronchodilators Global Market Report 2024, The bronchodilators market size is expected to see strong growth in the next few years. It will grow to $43.25 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing prevalence of COPD, rising awareness about lung diseases treatment aided with escalating research and development efforts, increase in prevalence of pulmonary disorders, the rise in disposable income, and increasing smoking rates. Major trends in the forecast period include advanced clinical research and innovative strategies, growing technological advancements, high prevalence of lung diseases such as COPD and asthma, new product launches, and rising number of patients with acute respiratory infections.

The increasing prevalence of chronic obstructive pulmonary disease (COPD) is expected to propel the growth of the bronchodilator market going forward. Chronic obstructive pulmonary disease is a progressive lung disease characterized by chronic inflammation of the airways and obstruction or limitation of airflow. Bronchodilators are used in chronic obstructive pulmonary disease (COPD) to relax the muscles around the airways, which helps to open the airways and make it easier to breathe. For instance, in March 2023, according to a report by the Scottish Public Health Observatory, led by Public Health Scotland, a UK-based Population Health Centre, COPD rates started to increase as the impact of COVID-19 eased. The rate in males increased from 83.2 to 97.6 cases per 100,000, and for females, the increase was from 72.6 to 97.3. Therefore, the increasing prevalence of chronic obstructive pulmonary disease (COPD) is driving the growth of the bronchodilator market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13816&type=smp

The bronchodilators market covered in this report is segmented –

1) By Type: Beta-Adrenergic Bronchodilators, Anticholinergic Bronchodilators, Xanthine Derivatives, Other Types
2) By Route of Administration: Oral, Nasal (Inhalation), Injectable
3) By Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Reactions, Breathing Problem, Other Indications
4) By End-User: Hospitals, Specialty Clinics, Other End Users

Major companies operating in the bronchodilator market are developing innovative products such as fixed-dose triple-drug combinations to better serve patients. A fixed-dose triple drug combination is a medication that contains three active ingredients in a single formulation, with each ingredient having a predetermined dose. For instance, in January 2023, Lupin, an India-based pharmaceutical firm, launched DIFIZMA, a fixed-dose triple-drug bronchodilator with a combination of indacaterol, glycopyrronium, and mometasone for managing asthma. DIFIZMA is offered as a dry powder inhalation. DIFIZMA is the only fixed-dose combination that has been approved by the Drug Controller General of India (DCGI) for the treatment of inadequately controlled asthma by improving lung function, providing better symptom control, and reducing exacerbations.

The bronchodilators market report table of contents includes:

1. Executive Summary
2. Bronchodilators Market Characteristics
3. Bronchodilators Market Trends And Strategies
4. Bronchodilators Market - Macro Economic Scenario
5. Global Bronchodilators Market Size and Growth
..............
32. Global Bronchodilators Market Competitive Benchmarking
33. Global Bronchodilators Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Bronchodilators Market
35. Bronchodilators Market Future Outlook and Potential Analysis
36. Appendix
Related Reports:
https://goodprnews.com/network-security-policy-management-npsm-software-market-players/
https://goodprnews.com/non-emergency-medical-transportation-market-size/
https://goodprnews.com/obstetrics-and-gynecology-ob-gyn-electronic-health-record-ehr-market-share/
https://goodprnews.com/online-grocery-market-players/
https://topprnews.com/network-security-policy-management-npsm-software-market-drivers/
https://topprnews.com/non-emergency-medical-transportation-market-drivers/
https://topprnews.com/obstetrics-and-gynecology-ob-gyn-electronic-health-record-ehr-market-insights/
https://topprnews.com/online-grocery-market-trends/


Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model